Wugan Zhao

1.0k total citations
19 papers, 788 citations indexed

About

Wugan Zhao is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Wugan Zhao has authored 19 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Pathology and Forensic Medicine and 6 papers in Cancer Research. Recurrent topics in Wugan Zhao's work include Viral-associated cancers and disorders (7 papers), Lymphoma Diagnosis and Treatment (7 papers) and MicroRNA in disease regulation (4 papers). Wugan Zhao is often cited by papers focused on Viral-associated cancers and disorders (7 papers), Lymphoma Diagnosis and Treatment (7 papers) and MicroRNA in disease regulation (4 papers). Wugan Zhao collaborates with scholars based in China and United States. Wugan Zhao's co-authors include Yihui Ma, Shuangni Yu, Zhaohui Lu, Jie Chen, Yumei Gu, Changzheng Liu, Jianping Liu, Yunxiao Meng, Jia Yu and Dandan Zhang and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Wugan Zhao

19 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wugan Zhao China 10 566 547 238 85 66 19 788
Christy L. Trejo United States 10 444 0.8× 206 0.4× 416 1.7× 51 0.6× 39 0.6× 12 670
Zizhen Zhang China 15 632 1.1× 595 1.1× 118 0.5× 35 0.4× 67 1.0× 29 852
Mingli Han China 14 683 1.2× 601 1.1× 161 0.7× 29 0.3× 27 0.4× 24 840
Mira Heinonen Finland 9 449 0.8× 221 0.4× 240 1.0× 103 1.2× 57 0.9× 9 635
Sylvia Mahara Singapore 8 502 0.9× 179 0.3× 210 0.9× 42 0.5× 20 0.3× 9 658
Ruoji Zhou United States 11 254 0.4× 189 0.3× 212 0.9× 91 1.1× 32 0.5× 28 483
Xuanfu Xu China 13 367 0.6× 156 0.3× 161 0.7× 38 0.4× 39 0.6× 19 499
Dabei Tang China 13 308 0.5× 293 0.5× 206 0.9× 46 0.5× 12 0.2× 26 575
Yongfeng Wu China 10 370 0.7× 293 0.5× 181 0.8× 27 0.3× 26 0.4× 13 558

Countries citing papers authored by Wugan Zhao

Since Specialization
Citations

This map shows the geographic impact of Wugan Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wugan Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wugan Zhao more than expected).

Fields of papers citing papers by Wugan Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wugan Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wugan Zhao. The network helps show where Wugan Zhao may publish in the future.

Co-authorship network of co-authors of Wugan Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Wugan Zhao. A scholar is included among the top collaborators of Wugan Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wugan Zhao. Wugan Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Liu, Enjie, Dandan Zhang, Wugan Zhao, et al.. (2023). The expression and clinical significance of PLK1/p-PLK1 protein in NK/T cell Lymphoma. Diagnostic Pathology. 18(1). 129–129. 4 indexed citations
2.
Wang, Guannan, Enjie Liu, Dandan Zhang, et al.. (2023). Clinicopathological features of CD5-positive splenic marginal zone lymphoma. Journal of Clinical Pathology. 77(6). 421–425. 1 indexed citations
4.
Zhao, Wugan, Min Zhang, Guannan Wang, et al.. (2022). GNAQ T96S mutation abrogates the ability of wild‐type GNAQ to induce apoptosis by phosphorylating annexin A2 in natural killer/T cell lymphoma. Cancer Science. 113(7). 2288–2296. 3 indexed citations
5.
He, Jun-Jun, Wei Ouyang, Wugan Zhao, et al.. (2021). Distinctive genomic characteristics in POLE/POLD1-mutant cancers can potentially predict beneficial clinical outcomes in patients who receive immune checkpoint inhibitor. Annals of Translational Medicine. 9(2). 129–129. 25 indexed citations
6.
Zhao, Huayan, Shenglei Li, Guannan Wang, et al.. (2019). Study of the mechanism by which dinaciclib induces apoptosis and cell cycle arrest of lymphoma Raji cells through a CDK1‐involved pathway. Cancer Medicine. 8(9). 4348–4358. 29 indexed citations
7.
Gao, Xianzheng, Guan‐Nan Wang, Wugan Zhao, et al.. (2019). Blocking OLFM4/HIF‐1α axis alleviates hypoxia‐induced invasion, epithelial–mesenchymal transition, and chemotherapy resistance in non‐small‐cell lung cancer. Journal of Cellular Physiology. 234(9). 15035–15043. 20 indexed citations
8.
Wang, Guannan, Yong Cui, Wugan Zhao, et al.. (2018). Clinicopathological analysis of the hydroa vacciniforme‑like lymphoproliferative disorder with natural killer cell phenotype compared with cutaneous natural killer T‑cell lymphoma. Experimental and Therapeutic Medicine. 16(6). 4772–4778. 1 indexed citations
9.
Wang, Guan‐Nan, Wugan Zhao, Ling Li, et al.. (2017). Prognostic significance of CD30 expression in nasal natural killer/T-cell lymphoma. Oncology Letters. 13(3). 1211–1215. 15 indexed citations
10.
Yu, Shuangni, Yihui Ma, Wugan Zhao, et al.. (2016). KRAS‐related noncoding RNAs in pancreatic ductal adenocarcinoma. Chronic Diseases and Translational Medicine. 2(4). 215–222. 5 indexed citations
11.
Wang, Guan‐Nan, Wugan Zhao, Xianzheng Gao, et al.. (2015). Primary natural killer/T cell lymphoma of the cervix: Case report and clinicopathological analysis. Taiwanese Journal of Obstetrics and Gynecology. 54(1). 71–74. 2 indexed citations
13.
Wang, Guan‐Nan, Xianzheng Gao, Wugan Zhao, et al.. (2015). [Presence of B-cell clones in angioimmunoblastic T cell lymphoma].. PubMed. 44(2). 106–10. 1 indexed citations
14.
Zhang, Fangbin, et al.. (2014). The Analysis of Factors Associated with Progression of Isolated Terminal Ileal Lesions. PLoS ONE. 9(3). e90797–e90797. 9 indexed citations
15.
Hu, Tengpeng, Xinhua Wang, Yu Chang, et al.. (2013). Follicular dendritic cell sarcoma of the pharyngeal region. Oncology Letters. 5(5). 1467–1476. 17 indexed citations
16.
Li, Lei, Jie Chen, Zhaohui Lu, et al.. (2011). [Significance of chemokine receptor CXCR3 expression in breast cancer].. PubMed. 40(2). 85–8. 10 indexed citations
17.
Yu, Shuangni, Zhaohui Lu, Changzheng Liu, et al.. (2010). miRNA-96 Suppresses KRAS and Functions as a Tumor Suppressor Gene in Pancreatic Cancer. Cancer Research. 70(14). 6015–6025. 278 indexed citations
18.
Ma, Yihui, Shuangni Yu, Wugan Zhao, Zhaohui Lu, & Jie Chen. (2010). miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2. Cancer Letters. 298(2). 150–158. 158 indexed citations
19.
Zhao, Wugan, Shuangni Yu, Zhaohui Lu, et al.. (2010). The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS. Carcinogenesis. 31(10). 1726–1733. 199 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026